AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/06/2024 | Press release | Distributed by Public on 05/07/2024 01:10
Please select the service you want to use:
Smartlinks | Comune di Sondrio | News | Local News | Politics and Policy | Government | Local Government | Top City Municipalities
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact